Kyverna Therapeutics (KYTX) EPS (Basic) (2023 - 2026)
Kyverna Therapeutics' (KYTX) quarterly EPS (Basic) came in at -$1.23 in Q1 2026, down 16.44% YoY from -$1.47 in Q1 2025, and down 43.95% on a QoQ basis from -$0.85 in Q4 2025.
Kyverna Therapeutics (KYTX) EPS (Basic) (2023 - 2026) Analysis & Trends
Kyverna Therapeutics (KYTX) has 4 years of EPS (Basic) data on file, last reported at -$1.23 in Q1 2026.
- Quarterly EPS (Basic) fell 16.44% year-over-year to -$1.23 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.46 (up 12.43% YoY) and the FY2025 annual result came in at -$4.62, down 35.95% from the prior year.
- EPS (Basic) eased to -$1.23 in Q1 2026, from -$0.85 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.85 in Q4 2025 to a low of -$30.63 in Q4 2023.
- A 4-year average of -$7.59 and a median of -$1.2 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 96.56% — and 2025, when it decreased 21.37%.
- Tracing KYTX's EPS (Basic) over 4 years: stood at -$30.63 in 2023, then surged by 96.56% to -$1.05 in 2024, then rose by 19.16% to -$0.85 in 2025, then tumbled by 43.95% to -$1.23 in 2026.
- The last three EPS (Basic) figures came in at -$1.23 (Q1 2026), -$0.85 (Q4 2025), and -$1.22 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Kyverna Therapeutics | 505.26 Mn | 505.26 Mn | - | -1.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.16 |
| Mar 31, 2026 | -1.23 |
| Dec 31, 2025 | -0.85 |
| Sep 30, 2025 | -1.22 |
| Jun 30, 2025 | -1.02 |
| Mar 31, 2025 | -1.05 |
| Dec 31, 2024 | -1.05 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -0.96 |
| Mar 31, 2024 | -1.20 |
| Dec 31, 2023 | -30.63 |
| Sep 30, 2023 | -24.08 |
| Jun 30, 2023 | -21.73 |
| Mar 31, 2023 | -12.66 |